Published in

American Association for the Advancement of Science, Science Translational Medicine, 325(8), 2016

DOI: 10.1126/scitranslmed.aad2355

Links

Tools

Export citation

Search in Google Scholar

Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

A nanoparticle formulation of an Aurora B kinase inhibitor uses ion pairing to achieve controlled release and efficacious, nontoxic target inhibition in tumors.